ArticleJournal of immunology research2025
Antiretroviral Therapy at Conception Leads to Lower Peripheral CD49a
Yanling Huo, Jinhee Kim, Deborah Kacanek, Sadia Samer, Elizabeth G Livingston, Elizabeth Stankiewicz Machado, Elena Martinelli
Abstract read
In one paragraphArticle in Journal of immunology research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Yanling HuoCenter for Biostatistics in AIDS Research (CBAR), Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Jinhee KimDepartment of Medicine Division of Infectious Diseases, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Deborah KacanekCenter for Biostatistics in AIDS Research (CBAR), Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Sadia SamerCell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Elizabeth Stankiewicz MachadoDepartment of Infectious Disease, University Hospital and Instituto De Pediatria Martagão Gesteira (IPPMG)-Federal University of Rio De Janeiro, Rio De Janeiro, Brazil.
Funding
LOC-IMPAACT Leadership GroupPharmacokinetics and Safety of Remdesivir for Treatment of COVID-19 in Pregnant Women in the USUM1AI068632 · NIAID · SOCIAL AND SCIENTIFIC SYSTEMS, INC. · PI Jennifer Jao, Sharon A Nachman · 2011 to 2026
$278.1MStatistical and Data Management Center-Pediatric,Adolescent, and Maternal CTGUM1AI068616 · NIAID · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Sean Scott Brummel, Marlene Ann Cooper · 2011 to 2026
$155.6MLC - IMPAACT Leadership GroupUM1AI106716 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Grace M Aldrovandi · 2014 to 2026
$47.2MVirology and Immunology Technology CoreP30AI117943 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Sahera Dirajlal-Fargo · 2015 to 2026
$38.4MHIV immune environment impact on pre-eclampsiaR03AI170156 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MARTINELLI, ELENA · 2022 to 2023
$160kNIAID NIH HHS P30 AI117943NIAID NIH HHS R03 AI170156NIAID NIH HHS UM1 AI068616NIAID NIH HHS UM1 AI068632NIAID NIH HHS UM1 AI106716NICHD NIH HHS HHSN275201800001CNICHD NIH HHS HHSN275201800001I
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Anti-Retroviral AgentsHIV InfectionsKiller Cells, NaturalPlasminogen Activator Inhibitor 2Pregnancy Complications, InfectiousAdolescentAdultFemaleFertilizationHumansInfectious Disease Transmission, VerticalPre-EclampsiaPregnancyAnti-Retroviral AgentsPlasminogen Activator Inhibitor 2
Identifiers
PMID40438469
PMCPMC12119168
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390